GW Pharmaceuticals Provides Update on Cannabinoid Pipeline
3/17/2014 9:04:10 AM
LONDON, March 17, 2014 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) (LSE:GWP) ("GW," "the Company" or "the Group"), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today provided an update on the Company's cannabinoid pipeline.
Help employers find you! Check out all the jobs and post your resume.
comments powered by